Success Story
OrganOx is at the forefront of changing the way donor organs are preserved in the critical time between donation and transplantation.
| Region/Nation | South East |
|---|---|
| Sector | Technology |
| Programme | Enterprise Capital Funds |
| Partner |
Its leading product, the metra®, harnesses patented medical technology to preserve donor livers for up to 24 hours prior to transplant. This product has been used in around 4,000 liver transplants.
OrganOx accessed venture capital via the Enterprise Capital Funds (ECF) programme, which it used to fund the clinical studies to secure market approval for its product, a complex class III medical device.
Tags related to this content:
More success stories
Read a success story about Ruuby
An on-demand beauty marketplace, which allows customers to order a host of beauty services to their desired location, has raised £2m to accelerate its growth in the North West by doubling down on its existing operations in Manchester and Liverpool.
Read a success story about Power Roll
Based in Murton, Power Roll, a pioneer in the solar energy transition, has raised £4.3 million in its most recent funding round, including £1.5 million from NPIF II – Maven Equity Finance, which is managed by Maven Capital Partners as part of the Northern Powerhouse Investment Fund II.
Read a success story about Xentra
A fast-growing Leeds cybersecurity company secured a six-figure loan from NPIF II – Mercia Debt Finance, which is managed by Mercia as part of the Northern Powerhouse Investment Fund II (NPIF II).